Publikationen von Gwendal Gränicher
Alle Typen
Zeitschriftenartikel (5)
2021
Zeitschriftenartikel
118 (12), S. 4720 - 4734 (2021)
A high cell density perfusion process for Modified Vaccinia virus Ankara production: process integration with inline DNA digestion and cost analysis. Biotechnology and Bioengineering
Zeitschriftenartikel
16 (1), e2000024 (2021)
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal 2020
Zeitschriftenartikel
8, 672 (2020)
Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode. Frontiers in Bioengineering and Biotechnology
Zeitschriftenartikel
104 (11), S. 4877 - 4888 (2020)
Performance of an Acoustic Settler Versus a Hollow Fiber-Based ATF Technology for Influenza Virus Production in Perfusion. Applied Microbiology and Biotechnology 2019
Zeitschriftenartikel
37 (47), S. 7019 - 7028 (2019)
Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1. Vaccine Buchkapitel (1)
2020
Buchkapitel
Perfusion Control for High Cell Density Cultivation and Viral Vaccine Production. In: Animal Cell Biotechnology, S. 141 - 168 (Hg. Pörtner, R.). Humana, New York (2020)
Meeting Abstract (1)
2018
Meeting Abstract
A new porcine suspension cell line (PBG.PK-21) provides efficient production for influenza and yellow fever vaccine viruses. In Vaccine Technology VII, 48. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
Vortrag (2)
2022
Vortrag
Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. Value through intensified bioprocessing II, Oxford, United Kingdom (2022)
Vortrag
Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. 27th ESACT Meeting, Lisbon (Portugal) (2022)
Hochschulschrift - Doktorarbeit (1)
2021
Hochschulschrift - Doktorarbeit
Process intensification and integration for the production of vaccines and viral vectors. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2021)